Pricing, Affordability & Value

Article

Smarter specialty spend in inflammatory care: Why adherence-focused models matter

Learn how adherence-focused specialty pharmacy care models reduce avoidable costs and improve outcomes in inflammatory care.

September 30, 25

Article

GLP-1s drive historic shift in traditional drug trend

GLP-1 medications drive unprecedented growth in traditional drug spending, surpassing specialty drug trends for the first time.

Ashley Holzworth-Nash, Pharm D, September 26, 25

Article

Express Scripts expands Patient Assurance Program to drive affordability and access to GLP-1s

July 10, 2025

Express Scripts will add GLP-1s for weight loss to the Patient Assurance Program (PAP), made possible by collaboration with Lilly and Novo Nordisk.

Newsroom

Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month

• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible • New offering helps employers meet growing ...

May 21, 25

Article

Most Favored Nation policy cannot succeed without the pharmacy benefit

Considering President Trump’s recent executive order, we examine the Most Favored Nation prescription drug pricing policy to the pharmacy benefit and discuss how removing PBMs – “the middleman” – is o...

May 20, 25

Article

Finding avenues to affordability for patients on specialty medications

Accredo has been helping patients access copay assistance programs for more than 10 years. Learn how copay assistance programs help patients access the care they need.

May 05, 25